Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

1799448

Aligos Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California. They are focused on developing best-in-class therapies for liver and viral diseases, specifically targeting areas with high unmet medical needs. Their pipeline includes treatments for chronic HBV infection and MASH. Aligos aims to significantly improve patient outcomes through science-driven approaches and a patient-centric focus.

86
Meget Pålitelig
Tillitsscore

Offisielt Register

Foretaksnavn
Aligos Therapeutics, Inc.
Organisasjonsnummer
1799448
MVA Nummer
000000000
Firmastatus
Active
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA 94080
Bransjekoder
Biological Products, (No Diagnostic Substances), 2836

AI Kvalitetsanalyse

Bransje
Biotechnology
SSL/HTTPS
Sikker
Profesjonell E-post
Ja
Kontakt E-post
info@aligos.com

🌟 Lignende Pålitelige Bedrifter

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Pålitelig

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, USA
Se profil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Meget Pålitelig

ArcticZymes Technologies er et bioteknologiselskap som spesialiserer seg på utvikling og produksjon av enzymer. De tilbyr nukleaser for bioframstilling og molekylær diagnostikk, inkludert Saltaktive nukleaser (SAN). Selskapet er kjent for sine polymeraser og enzymer brukt i forskning og industrielle anvendelser.

Sykehusvegen 23, Norge
Se profil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Meget Pålitelig

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Norge10 ansatte
Se profil